Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Understanding Improved Survival Among Black Individuals with Myelodysplastic Syndromes

Naman Sharma, Yating Wang, Hossein Sadrzadeh, Angela C. Tramontano, John Mark Sloan, Richard M. Stone, Lachelle D. Weeks

Blood (2024) 144 (Supplement 1): 2417.

https://doi.org/10.1182/blood-2024-207635

Published: 2024

Journal Articles

Chemotherapy-induced reversal of ciltacabtagene autoleucel–associated movement and neurocognitive toxicity

Charlotte E. Graham, Won-Ho Lee, Hadley R. Wiggin, Valentina M. Supper, Mark B. Leick, Filippo Birocchi, Andrew J. Yee, Angelina Petrichenko, John Everett, Frederic D. Bushman, Hossein Sadrzadeh, Otto Rapalino, Daniel Chiu, Isabel Arrillaga-Romany, Marcela V. Maus, Matthew J. Frigault, Kathleen M. E. Gallagher

Blood (2023) 142 (14): 1248–1252.

https://doi.org/10.1182/blood.2023021429

Published: 2023

Includes: Supplemental data

Journal Articles

Myelodysplastic syndrome presenting as thrombotic microangiopathy

Hossein Sadrzadeh, Eric Burks

Blood (2020) 136 (20): 2359.

https://doi.org/10.1182/blood.2020008362

Published: 2020

Journal Articles

Use of 2HG Levels in the Serum, Urine, or Bone Marrow to Predict IDH Mutations in Adults with Acute Myeloid Leukemia

Andrew M. Brunner, MD, Donna S Neuberg, ScD, Seth A. Wander, MD PhD, Hossein Sadrzadeh, MD, Karen K. Ballen, MD, Philip C. Amrein, MD, Gabriela S. Hobbs, MD, Yi-Bin Chen, MD, Ashley M. Perry, BS, Christelle Joseph, Meghan E. Burke, Aura Y Ramos, Regina Silver, Ilene Galinsky, ANP, Sophia Adamia, PhD, Darrell Borger, PhD, Anthony J Iafrate, MD PhD, Richard M. Stone, MD, Amir T. Fathi, MD

Blood (2015) 126 (23): 2597.

https://doi.org/10.1182/blood.V126.23.2597.2597

Published: 2015

Journal Articles

Primary Cardiac Burrkit Lymphoma: Characteristics, Clinical Presentation and Outcome

Mohamed Jumayli, MD, Emily Chen, MD, Hossein Sadrzadeh, MD

Blood (2015) 126 (23): 5048.

https://doi.org/10.1182/blood.V126.23.5048.5048

Published: 2015

Journal Articles

The End of Life for Patients with Acute Myeloid Leukemia (AML)- a Single Center Experience

Judy Foster, NP, Traci M. Blonquist, Areej El-Jawahri, MD, Amir T Fathi, MD, Philip C. Amrein, MD, Hossein Sadrzadeh, MD, Andrew M. Brunner, MD, Gabriella Hobbs, MD, Eyal C. Attar, MD, Donna S Neuberg, ScD, Karen K. Ballen, MD

Blood (2015) 126 (23): 3318.

https://doi.org/10.1182/blood.V126.23.3318.3318

Published: 2015

Journal Articles

AG-120, an Oral, Selective, First-in-Class, Potent Inhibitor of Mutant IDH1, Reduces Intracellular 2HG and Induces Cellular Differentiation in TF-1 R132H Cells and Primary Human IDH1 Mutant AML Patient Samples Treated Ex Vivo

Erica Hansen, Cyril Quivoron, Kim Straley, René M Lemieux, Janeta Popovici-Muller, Hossein Sadrzadeh, Amir T Fathi, Camelia Gliser, Muriel David, Véronique Saada, Jean-Baptiste Micol, Olivier Bernard, Marion Dorsch, Hua Yang, Michael Su, Sam Agresta, Stéphane de Botton, Virginie Penard-Lacronique, Katharine Yen

Blood (2014) 124 (21): 3734.

https://doi.org/10.1182/blood.V124.21.3734.3734

Published: 2014

Journal Articles

T Cell Exhaustion and Downregulation of Cytotoxic NK Cells – an Immune Escape Mechanism in Adult Acute Lymphoblastic Leukemia

Eolia Brissot, Sawa Ito, MD, Kit Lu, MD, Carly Cantilena, B. Douglas Smith, Gabrielle Prince, Hossein Sadrzadeh, Amir T Fathi, Stephen A. Strickland, MD MSCI, Nancy F. Hensel, Fariba Chinian, M.S., Keyvan Keyvanfar, BS, Minoo Battiwalla, MDMS, Pawel Muranski, MD, Christopher S. Hourigan, MDPhD, John Barrett, MD

Blood (2014) 124 (21): 3781.

https://doi.org/10.1182/blood.V124.21.3781.3781

Published: 2014

Journal Articles

Diagnostic Features and 2-Hydroxyglutarate (2-HG) Levels Among Acute Myeloid Leukemia (AML) Patients with and without Isocitrate Dehydrogenase (IDH) Mutations

Blood (2014) 124 (21): 1045.

https://doi.org/10.1182/blood.V124.21.1045.1045

Published: 2014

Journal Articles

Trends In Outcomes In Core Binding Factor Acute Myeloid Leukemia: A SEER Database Analysis

Andrew M. Brunner, MD, Traci Blonquist, MS, Hossein Sadrzadeh, MD, Yi-Bin Chen, MD, Donna S. Neuberg, ScD, Amir T. Fathi, MD

Blood (2013) 122 (21): 3880.

https://doi.org/10.1182/blood.V122.21.3880.3880

Published: 2013

Journal Articles

FLT3 inhibitor-induced neutrophilic dermatosis

Amir T. Fathi, Long Le, Robert P. Hasserjian, Hossein Sadrzadeh, Mark Levis, Yi-Bin Chen

Blood (2013) 122 (2): 239–242.

https://doi.org/10.1182/blood-2013-01-478172

Published: 2013

Journal Articles

AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway

Yiyun Zhang, Jianfeng Wang, Justin Wheat, Xi Chen, Shan Jin, Hossein Sadrzadeh, Amir T. Fathi, Randall T. Peterson, Andrew L. Kung, David A. Sweetser, Jing-Ruey Joanna Yeh

Blood (2013) 121 (24): 4906–4916.

https://doi.org/10.1182/blood-2012-08-447763

Published: 2013

Includes: Supplemental data

Journal Articles

Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response

Blood (2012) 120 (23): 4649–4652.

https://doi.org/10.1182/blood-2012-06-438267

Published: 2012

Includes: Supplemental data

Journal Articles

Association of Baseline Body Mass Index (BMI) with Overall Survival Among Patients Over Age 60 with Acute Myeloid Leukemia (AML)

Andrew M. Brunner, MD, Yang Feng, PhD, Benjamin J. Drapkin, MD, Hossein Sadrzadeh, MD, Karen K. Ballen, MD, Eyal C. Attar, MD, Philip C. Amrein, MD, Steven L. McAfee, MD, Donna S. Neuberg, ScD, Amir T Fathi, MD

Blood (2012) 120 (21): 1484.

https://doi.org/10.1182/blood.V120.21.1484.1484

Published: 2012

Journal Articles

Trends in All-Cause Mortality Among Older Patients with CML: A SEER Database Analysis

Andrew M. Brunner, MD, Federico Campigotto, MS, Benjamin J. Drapkin, MD, Hossein Sadrzadeh, MD, Donna S. Neuberg, ScD, Amir T Fathi, MD

Blood (2012) 120 (21): 3772.

https://doi.org/10.1182/blood.V120.21.3772.3772

Published: 2012

Journal Articles

Granulocytic Sarcoma, A Single-Institution Survey of Clinical Presentation and Trajectory

Hossein Sadrzadeh, MD, Nathan Deysher, Layli Jamali, MD, Andrew M. Brunner, MD, Benjamin J. Drapkin, MD, Karen K. Ballen, MD, Eyal C. Attar, MD, Philip C. Amrein, MD, Steven L. McAfee, Amir T Fathi, MD

Blood (2012) 120 (21): 1041.

https://doi.org/10.1182/blood.V120.21.1041.1041

Published: 2012

Journal Articles

A Comparative Retrospective Survey of Reinduction Chemotherapy Regimens for Acute Myeloid Leukemia (AML) in First Relapse: A Single-Institution Experience

Andrew Brunner, MD, Hossein Sadrzadeh, MD, Lillian Werner, Karen K. Ballen, MD, Yi-Bin A. Chen, MD, Philip C. Amrein, MD, Eyal C. Attar, MD, Steven L. McAfee, MD, Thomas R. Spitzer, MD, Donna Neuberg, ScD, Amir T Fathi, MD

Blood (2011) 118 (21): 4273.

https://doi.org/10.1182/blood.V118.21.4273.4273

Published: 2011

NARROW

Understanding Improved Survival Among Black Individuals with Myelodysplastic Syndromes

Chemotherapy-induced reversal of ciltacabtagene autoleucel–associated movement and neurocognitive toxicity

Myelodysplastic syndrome presenting as thrombotic microangiopathy

Use of 2HG Levels in the Serum, Urine, or Bone Marrow to Predict IDH Mutations in Adults with Acute Myeloid Leukemia

Primary Cardiac Burrkit Lymphoma: Characteristics, Clinical Presentation and Outcome

The End of Life for Patients with Acute Myeloid Leukemia (AML)- a Single Center Experience

AG-120, an Oral, Selective, First-in-Class, Potent Inhibitor of Mutant IDH1, Reduces Intracellular 2HG and Induces Cellular Differentiation in TF-1 R132H Cells and Primary Human IDH1 Mutant AML Patient Samples Treated Ex Vivo

T Cell Exhaustion and Downregulation of Cytotoxic NK Cells – an Immune Escape Mechanism in Adult Acute Lymphoblastic Leukemia

Diagnostic Features and 2-Hydroxyglutarate (2-HG) Levels Among Acute Myeloid Leukemia (AML) Patients with and without Isocitrate Dehydrogenase (IDH) Mutations

Trends In Outcomes In Core Binding Factor Acute Myeloid Leukemia: A SEER Database Analysis

FLT3 inhibitor-induced neutrophilic dermatosis

AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway

Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response

Association of Baseline Body Mass Index (BMI) with Overall Survival Among Patients Over Age 60 with Acute Myeloid Leukemia (AML)

Trends in All-Cause Mortality Among Older Patients with CML: A SEER Database Analysis

Granulocytic Sarcoma, A Single-Institution Survey of Clinical Presentation and Trajectory

A Comparative Retrospective Survey of Reinduction Chemotherapy Regimens for Acute Myeloid Leukemia (AML) in First Relapse: A Single-Institution Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only